Celera Revenues Up as Loss Declines in Q1

May 06, 2009

NEW YORK (GenomeWeb News) – Celera reported after the close of the market on Wednesday that its first-quarter revenues increased 16 percent, while the firm cut its net loss significantly on lower charges year over year.

The Alameda, Calif.-based molecular diagnostics firm generated revenues of $45.7 million for the three-month period ended March 28, compared to revenues of $39.5 million for the first quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Helix Launches 'App Store'

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

More CAR-T Therapies Sought

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Telomeres of Spawning Salmon

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

This Week in PLOS

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

Main menu